Targeting Cholesterol Metabolism as Efficient Antiviral Strategy Against the Hepatitis E Virus

Summary of the British Transplantation Society UK Guidelines for Hepatitis E and Solid Organ Transplantation

(2018) Stuart McPherson et al.   TRANSPLANTATION

Inhibition of Hepatitis E Virus Spread by the Natural Compound Silvestrol

(2018) Mirco Glitscher et al.   Viruses-Basel

Late Endosomal/Lysosomal Cholesterol Accumulation Is a Host Cell-Protective Mechanism Inhibiting Endosomal Escape of Influenza A Virus

(2018) Alexander Kühnl et al.   mBio

Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial

(2018) Gideon M. Hirschfield et al.   JOURNAL OF HEPATOLOGY

Genotype specific pathogenicity of hepatitis E virus at the human maternal-fetal interface

(2018) Jordi Gouilly et al.   Nature Communications

ICTV Virus Taxonomy Profile: Hepeviridae

(2017) Michael A. Purdy et al.   JOURNAL OF GENERAL VIROLOGY

Characterization of the Quasi-Enveloped Hepatitis E Virus Particles Released by the Cellular Exosomal Pathway

(2017) Shigeo Nagashima et al.   JOURNAL OF VIROLOGY

Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity

(2016) Yannick Debing et al.   JOURNAL OF HEPATOLOGY

Enhanced Replication of Hepatitis E Virus Strain 47832c in an A549-Derived Subclonal Cell Line

(2016) Mathias Schemmerer et al.   Viruses-Basel

Apolipoprotein E and protection against hepatitis E viral infection in American non-Hispanic blacks

(2015) Lyna Zhang et al.   HEPATOLOGY

Hepatitis E Virus Enters Liver Cells Through a Dynamin-2, Clathrin and Membrane Cholesterol-Dependent Pathway

(2015) Prasida Holla et al.   TRAFFIC

Hepatitis E virus infection in Latin America: A review

(2013) J.M. Echevarría et al.   JOURNAL OF MEDICAL VIROLOGY

An ORF1-rearranged hepatitis E virus derived from a chronically infected patient efficiently replicates in cell culture

(2013) R. Johne et al.   JOURNAL OF VIRAL HEPATITIS

Cyclosporine A and PSC833 inhibit ABCA1 function via direct binding

(2012) Kohjiro Nagao et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Fiji: an open-source platform for biological-image analysis

(2012) Johannes Schindelin et al.   NATURE METHODS

MVB vesicle formation: ESCRT-dependent, ESCRT-independent and everything in between

(2011) Markus Babst   CURRENT OPINION IN CELL BIOLOGY

The global burden of hepatitis E virus genotypes 1 and 2 in 2005

(2011) David B. Rein et al.   HEPATOLOGY

Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virions

(2011) S. Nagashima et al.   JOURNAL OF GENERAL VIROLOGY

Plasma peptidome profiling of acute hepatitis E patients by MALDI-TOF/TOF

(2011) Shikha Taneja et al.   Proteome Science

Dyslipidemia and lipid management in HIV-infected patients

(2011) Janet Lo   Current Opinion in Endocrinology Diabetes and Obesity

Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitro

(2010) Ted Bader et al.   ANTIVIRAL RESEARCH

A PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells

(2010) S. Nagashima et al.   JOURNAL OF GENERAL VIROLOGY

Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient

(2010) N. Kamar et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION